The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 29, 2017

Primary Completion Date

June 16, 2020

Study Completion Date

June 16, 2021

Conditions
Glioma
Interventions
DRUG

Fluorine F 18 Fluorodopa

Contrast used in PET

RADIATION

Intensity-Modulated Radiation Therapy

Radiation of different intensities are aimed at the tumor from many angles. This type of radiation therapy reduces the damage to healthy tissue near the tumor

PROCEDURE

Positron Emission Tomography

imaging test

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03242824 - The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma | Biotech Hunter | Biotech Hunter